Iambic Therapeutics files for Nasdaq IPO

Published Monday, September 21, 2026 · 7:20 PM EDT

AI-assisted drug developer Iambic Therapeutics filed for an initial public offering and applied to list on the Nasdaq Global Select Market under the symbol IAM. The preliminary prospectus does not specify the number of shares, price range or expected proceeds. Iambic combines predictive AI models with automated chemistry and biology experiments to select and optimize drug candidates. Its lead program, IAM1363, is in a Phase 1/1b trial for HER2-altered solid tumors, while two other programs remain preclinical. The company cautioned that its platform has not produced an approved drug.

Sources

SEC EDGAR

Published by Tech & Business, a media brand covering technology and business. This story was sourced from SEC EDGAR and reviewed by the T&B editorial agent team.

Back to Newswire

Keep reading

Full wire

Robotics Capital

Zipline closes $1.5 billion funding at $21.5 billion valuation

Zipline has closed $1.5 billion in fresh funding at a valuation of $21.5 billion, Bloomberg reports. The financing for the drone delivery and logistics startup comes as it expands its commercial partnership with retailer Walmart Inc.

Capital Infrastructure

VÆRIDION raises €30 million and wins selection for €94.5 million EU grant

Munich electric aircraft developer VÆRIDION has raised €30 million in Series A2 financing and been selected for a €94.5 million European Commission Innovation Fund grant, EU-Startups reports. SHIFT Invest and Invest-NL co-led the equity round.

AI Capital

Numica raises $21M to acquire small US accounting practices

Numica has raised $21M in equity and debt from Roosh X and Flashpoint Capital to acquire more small US accounting firms, The Next Web reports. The New York startup targets practices with annual revenue of $700,000 to $5m, often owned by accountants approaching retirement.

Capital

FluoRok raises €26.64 million to scale fluorochemical manufacturing

Oxford-based FluoRok has secured €26.64 million ($30 million) in Series A financing to expand production of fluorochemicals without hazardous hydrogen fluoride.

Capital Infrastructure

Green Voltis raises €13.5 million for battery trading and energy operations

Stockholm-based Green Voltis has raised €13.5 million in Series A financing from sole investor Lochpine Capital, EU-Startups reports. The company operates and trades battery storage across European power markets, with more than 1.2 GWh under contract and in operation.

Capital AI

Mindmax raises $3.3m for conversational AI exam tutor

London startup Mindmax announced $3.3m (£2.5m) in pre-seed funding to build an AI tutor for professional exams and workplace skills. Concept Ventures led the round, joined by Redrice Ventures, Daybreak Ventures and Lerer Hippeau.